US Activist Hedge Fund Institutional SEC 13D 13G — October 07, 2026

07-10-2026

Philip A. Norcross and affiliated entities (GAH Capital, LLC and GAH Capital Trust) filed Amendment No. 7 to their Schedule 13D, disclosing aggregate beneficial ownership of 2,451,458 shares (9.68%) of Mid Penn Bancorp common stock. The group received regulatory approvals from the Federal Reserve and the Pennsylvania Department of Banking and Securities to potentially increase ownership up to 24.99%, though no additional purchases are assured. The filing states the investment is for investment purposes with no current plans for major corporate changes.

• · The Reporting Persons received a notice of non-objection from the Federal Reserve on October 5, 2026, and approval from the Pennsylvania Department of Banking and Securities on September 21, 2026, allowing future acquisitions above 9.9% up to 24.99%.
• · The group's ownership is 9.68%, which is below the 9.9% threshold that previously required prior approval under the CIBCA.
• · The filing is an amendment to the original Schedule 13D filed on November 8, 2024.
• · The Reporting Persons have no current plans for liquidation, merger, sale of assets, or changes to the board or senior management.
• · Alexander S. Norcross, a descendant of George E. Norcross, III, is an Assistant Vice President and Private Banker at Mid Penn Bank, the subsidiary bank of the Issuer.

07-10-2026

Jakhongir Abidovich Artikkhodjaev transferred 1,000,000 shares of StageWise Strategies Corp. (STWI) to his controlled entity, Tourism and Entertainment Group LLC (TEG LLC), on October 5, 2026, for US$138,268 (US$0.138 per share). Following the transfer, Artikkhodjaev's direct ownership dropped to zero, but he retains beneficial ownership of approximately 79.3% of the company through TEG LLC, which now holds about 59.5% directly. Additionally, a Share Exchange Agreement dated October 6, 2026, provides for the Issuer to acquire substantially all equity interests of TEG SPV, making it a wholly-owned subsidiary upon closing.

• · The transfer was executed under a Contribution Agreement dated October 5, 2026, and the shares were valued at 1,667.622 sum per share per an independent appraisal.
• · The transferred shares represent 19.824% of the total issued shares (5,044,334).
• · TEG LLC's charter fund increased to 352,025,622,560.87 sum, with Artikkhodjaev's stake in TEG LLC at 99.9262292%.
• · A Share Exchange Agreement dated October 6, 2026, provides for the Issuer to acquire substantially all equity interests of TEG SPV, making it a wholly-owned subsidiary upon closing.
• · No other transactions involving the Issuer's shares have occurred since the most recent Schedule 13D filing.

07-10-2026

L1 Capital Pty Ltd disclosed a 10.24% beneficial ownership stake in Sigma Lithium Corp as of September 30, 2026, holding 11,522,140 common shares. The filing is a Schedule 13G, indicating passive investment intent. The stake is held through multiple funds managed by L1 Capital.

• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · L1 Capital is an Australian investment manager and Australian Financial Services License holder regulated by ASIC.
• · The shares are listed on NASDAQ.

07-10-2026

Ka Kin Law filed an amended Schedule 13G with the SEC on October 7, 2026, disclosing direct beneficial ownership of 1,262,795 Class A Ordinary Shares of Mint Inc Ltd, representing 9.95% of the Class A shares and 4.73% of the issuer's aggregate voting power. The filing notes that Mr. Law no longer holds any shares through AL Holding Group Limited, with all shares now held directly.

• · This is Amendment No. 3 to the Schedule 13G initially filed on May 28, 2025.
• · Mr. Law's business address is 17/F, Wing Kwok Centre, No.182 Woosung Street, Jordan, Kowloon, Hong Kong.
• · The filing is made under Rule 13d-1(c) and includes a certification that the securities were not acquired to change or influence control of the issuer.
• · Class B Ordinary Shares carry 20 votes per share, significantly diluting the voting power of Class A shares.

07-10-2026

Federated Hermes, Inc. and related parties filed an amended Schedule 13G disclosing beneficial ownership of 4,965,414 shares of aTYR PHARMA INC common stock as of September 30, 2026, representing a 5.06% stake. The filing is made by the parent holding company and its controlling trust and trustees, who expressly disclaim beneficial ownership of the securities held by managed funds. No period-over-period comparison is available as this is an initial/amended filing without prior period data.

• · The filing is an amendment to Schedule 13G (SC 13G/A) filed on October 7, 2026.
• · The reporting persons include Federated Hermes, Inc., Voting Shares Irrevocable Trust, and trustees Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue.
• · All parties expressly disclaim beneficial ownership of the securities under Rule 13d-4.
• · The investment adviser Federated Global Investment Management Corp. is a wholly owned subsidiary of FII Holdings, Inc., which is wholly owned by Federated Hermes, Inc.

07-10-2026

Federated Hermes, Inc. and related entities filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 1,678,069 shares of Arcturus Therapeutics Holdings Inc. common stock as of September 30, 2026, representing 5.90% of the outstanding shares. The filing is a routine disclosure of a passive stake held by registered investment companies and separate accounts advised by Federated Hermes subsidiaries, with the reporting persons expressly disclaiming beneficial ownership under Rule 13d-4.

• · The filing is an amendment (Schedule 13G/A) filed on October 7, 2026, with a date of change of October 7, 2026.
• · The reported shares are held by registered investment companies and separate accounts advised by subsidiaries of Federated Hermes, Inc.
• · All reporting persons expressly disclaim beneficial ownership of the securities under Rule 13d-4.
• · The filing is made pursuant to Rule 13d-1(b), indicating a passive investment intent.

07-10-2026

Federated Hermes, Inc. and related entities filed a Schedule 13G/A with the SEC on October 7, 2026, disclosing beneficial ownership of 4,049,974 shares of LifeMD, Inc. common stock, representing an 8.40% stake. The filing is an amendment to a previous Schedule 13G and confirms that the shares are held in the ordinary course of business by registered investment companies and separate accounts advised by Federated Hermes subsidiaries. The reporting persons, including the Voting Shares Irrevocable Trust and the Donahue trustees, expressly disclaim beneficial ownership of the securities.

• · The filing is an amendment (SC 13G/A) to a prior Schedule 13G, indicating a change in the filing but not necessarily a change in ownership level.
• · The shares are held by registered investment companies and separate accounts advised by Federated Hermes MDTA LLC and Federated Investment Counseling, which are wholly owned subsidiaries of Federated Hermes, Inc.
• · All voting stock of Federated Hermes, Inc. is held by the Voting Shares Irrevocable Trust, with Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue as trustees.
• · The reporting persons disclaim beneficial ownership of the securities under Rule 13d-4 of the Exchange Act.

07-10-2026

Federated Hermes, Inc. and related parties filed an amended Schedule 13G with the SEC on October 7, 2026, reporting beneficial ownership of 6,934,414 shares of EyePoint, Inc. common stock, representing 8.04% of the company's outstanding shares. The filing expressly disclaims beneficial ownership of the securities, which are held by managed funds and separate accounts advised by Federated Hermes subsidiaries. The reporting persons include Federated Hermes, Inc., the Voting Shares Irrevocable Trust, and several individual trustees, all of whom disclaim beneficial ownership.

• · The filing is an amendment to Schedule 13G, filed pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The reporting persons expressly disclaim beneficial ownership of the securities under Rule 13d-4.
• · The Voting Shares Irrevocable Trust and the Donahue family trustees (Thomas R. Donahue, Ann C. Donahue, J. Christopher Donahue) are among the reporting persons.
• · The filing includes a joint filing agreement and power of attorney as exhibits.

07-10-2026

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation filed a Schedule 13G/A disclosing aggregate beneficial ownership of 39,779 shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF - October (a series of First Trust Exchange-Traded Fund VIII), representing 3.98% of the issuer's outstanding shares. The filing notes that the shares are held primarily by unit investment trusts sponsored by First Trust Portfolios L.P., and that none of the reporting persons has the power to vote those shares. All reporting persons disclaim beneficial ownership of the shares.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b).
• · The reporting persons are filing jointly pursuant to Rule 13d-1(k)(1).
• · First Trust Portfolios L.P. acts as sponsor of certain unit investment trusts which hold the shares; First Trust Advisors L.P. acts as portfolio supervisor; The Charger Corporation is the General Partner of both.
• · No individual unit investment trust holds more than 3% of any registered investment company issuer's shares.
• · The shares are voted by the trustee of such unit investment trusts to match the general proportion of other shareholders' votes.
• · The reporting persons disclaim beneficial ownership of the shares identified in the filing.

07-10-2026

FMR LLC filed an amended Schedule 13G with the SEC on October 7, 2026, reporting beneficial ownership of 4,510 shares of Proficient Auto Logistics, Inc (PAL) common stock as of September 30, 2026, representing 0.0% of the outstanding shares. The filing indicates FMR LLC's ownership is passive and not intended to influence control of the company. This is a routine disclosure of a major shareholder's holdings, with no change in ownership percentage reported.

• · FMR LLC's ownership is passive and not intended to influence control of Proficient Auto Logistics, Inc.
• · The filing is an amendment to a previous Schedule 13G, indicating a routine update of holdings.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) between FMR LLC and Abigail P. Johnson.

07-10-2026

FMR LLC filed a Schedule 13G/A with the SEC on October 7, 2026, disclosing beneficial ownership of 2,866,144 Class A common shares of Baldwin Insurance Group, Inc. (BWIN), representing 3.0% of the outstanding Class A common stock as of September 30, 2026. The filing, made jointly with Abigail P. Johnson and other FMR entities, indicates the shares are held in the ordinary course of business and not for control purposes. No material change in ownership percentage was indicated in the filing.

• · Filing date: October 7, 2026; beneficial ownership determined as of September 30, 2026.
• · FMR LLC and its affiliates hold 2,866,144 shares, representing 3.0% of the outstanding Class A common stock.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · Abigail P. Johnson and the Johnson family may be deemed to form a controlling group with respect to FMR LLC through voting agreements.
• · No single other person's interest exceeds 5% of the outstanding Class A common stock.

07-10-2026

FMR LLC (Fidelity) disclosed a 10.2% beneficial ownership stake in Eikon Therapeutics, Inc. as of September 30, 2026, holding 5,520,152 shares of common stock. The filing is an amendment (SC 13G/A) and reflects Fidelity's passive investment in the biotech company, with no intent to change or influence control.

• · FMR LLC's beneficial ownership includes shares held by subsidiaries FIAM LLC, Fidelity Management & Research Company LLC, and Fidelity Management Trust Company.
• · Abigail P. Johnson and the Johnson family group hold 49% voting power of FMR LLC through Series B voting common shares and a voting agreement.
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · No single other person beneficially owns more than 5% of the outstanding common stock.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC disclosing beneficial ownership of 15,774,196.20 shares of Astera Labs, Inc. common stock as of September 30, 2026, representing a 9.1% stake. The filing confirms Fidelity's passive investment in the semiconductor company, with no intent to change or influence control.

• · The filing is an amendment to Schedule 13G, indicating a change in ownership since the prior filing.
• · FMR LLC's ownership is classified as passive under Rule 13d-1(b), with no control intent.
• · Abigail P. Johnson and the Johnson family hold 49% voting power of FMR LLC through Series B voting common shares.
• · Fidelity Management & Research Company LLC beneficially owns 5% or greater of the outstanding shares.
• · The filing date is October 7, 2026, with ownership measured as of September 30, 2026.

07-10-2026

FMR LLC filed an amendment to its Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 6,385,120.50 shares of Privia Health Group, Inc. common stock, representing 5.0% of the outstanding shares as of September 30, 2026. The filing reflects FMR's passive investment position and includes a joint filing agreement among FMR entities and Abigail P. Johnson. No change in control or activist intent is indicated.

• · Filing date: October 7, 2026; beneficial ownership as of September 30, 2026.
• · FMR LLC is a Delaware entity; shares held in ordinary course of business, not for control purposes.
• · Johnson family group holds 49% voting power of FMR LLC through Series B shares and a voting agreement.
• · Joint filing agreement under Rule 13d-1(k)(1) executed October 6, 2026.

07-10-2026

FMR LLC (parent of Fidelity) filed a Schedule 13G/A disclosing beneficial ownership of 1,736,979 common shares of Immunocore Holdings plc as of September 30, 2026, representing 3.6% of outstanding shares. The filing is an amendment to a prior 13G and reflects a decrease from the previous reporting period, as the filing type indicates a change in ownership. Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported as a beneficial owner with the same share count.

• · FMR LLC's filing is an amendment (Schedule 13G/A) indicating a change in ownership from a prior filing.
• · No single other person's interest in the common stock exceeds 5% of total outstanding shares.
• · The filing is made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to change or influence control.
• · Abigail P. Johnson is deemed to have beneficial ownership through her role and family's controlling interest in FMR LLC.
• · The Johnson family group holds 49% of the voting power of FMR LLC through Series B voting common shares and a voting agreement.

07-10-2026

FMR LLC filed an amendment to its Schedule 13G, reporting beneficial ownership of 4,222,633 Subordinate Voting Shares of BRP Inc., representing 11.6% of the class as of September 30, 2026. The filing reflects FMR's continued significant stake, with no change in control intent, and includes a joint filing agreement among FMR entities. No negative or declining metrics were reported in this ownership disclosure.

• · Filing date: October 7, 2026; beneficial ownership determined as of September 30, 2026.
• · FMR LLC's ownership increased by 10,000 shares from the prior 13G (4,212,633 to 4,222,633), but the percentage remained at 11.6%.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1).
• · Abigail P. Johnson and the Johnson family may be deemed to form a controlling group with respect to FMR LLC through a voting agreement.

07-10-2026

FMR LLC (Fidelity) filed a Schedule 13G disclosing beneficial ownership of 16,169,439.04 shares of Illumina, Inc. common stock, representing a 10.7% stake as of September 30, 2026. The filing confirms Fidelity's position as a significant minority shareholder in Illumina, with the shares held in the ordinary course of business and not for control purposes. The filing also notes that no other single person's interest in the stock exceeds 5% of the total outstanding shares.

• · FMR LLC's filing is made under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Illumina.
• · Abigail P. Johnson and the Johnson family are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of the voting power, and may be deemed a controlling group under the Investment Company Act of 1940.
• · The filing includes a Rule 13d-1(k)(1) agreement for joint filing on behalf of FMR LLC and Abigail P. Johnson.
• · No prior period comparison data is available in this filing to assess changes in ownership percentage.

07-10-2026

FMR LLC (Fidelity) disclosed a 6.9% beneficial ownership stake in Korsana Biosciences, Inc. (formerly Cyclerion Therapeutics, Inc.) as of September 30, 2026, holding 3,144,797 shares of common stock. The filing is an amendment to Schedule 13G and reflects Fidelity's passive investment in the company, with no intent to influence control.

• · The filing is an amendment (SC 13G/A) filed on October 7, 2026, with a date of change of October 6, 2026.
• · The subject company changed its name from Cyclerion Therapeutics, Inc. to Korsana Biosciences, Inc. effective October 4, 2018.
• · FMR LLC's ownership is classified as 'HC' (Holding Company) under Rule 13d-1(b).
• · Abigail P. Johnson is also reported as a beneficial owner with the same 6.9% stake, classified as 'IN' (Individual).
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) between FMR LLC and Abigail P. Johnson.

07-10-2026

FMR LLC disclosed a 8.2% beneficial ownership stake in ON SEMICONDUCTOR CORP as of September 30, 2026, holding 31,915,449.72 shares of common stock. The filing is an amendment to Schedule 13G, indicating passive investment intent, and includes a joint filing agreement among FMR entities. No change in ownership percentage was reported compared to the prior filing, suggesting a stable position.

• · FMR LLC's filing is an amendment to Schedule 13G, indicating passive investment intent.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1).
• · FMR LLC's beneficial ownership is held through various subsidiaries, with Fidelity Management & Research Company LLC owning 5% or more.
• · Abigail P. Johnson and the Johnson family control FMR LLC through a voting agreement.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 9,289,705.35 common shares of NXP Semiconductors N.V. as of September 30, 2026. This represents a 3.7% stake in the company, held in the ordinary course of business and not for control purposes. The filing confirms Fidelity's passive investment position in NXP, with no single underlying entity holding more than 5% of the outstanding shares.

• · Filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · FMR LLC has sole voting power over 8,537,487.30 shares and sole dispositive power over 9,289,705.35 shares.
• · Abigail P. Johnson, as Chairman and CEO, is also a reporting person with the same 3.7% beneficial ownership.
• · The Johnson family, through voting agreements, may be deemed a controlling group of FMR LLC under the Investment Company Act of 1940.
• · No single person other than the reporting entities has an interest exceeding 5% of the outstanding common stock.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 18,225,634.83 shares of ExlService Holdings, Inc. common stock as of September 30, 2026, representing a 12.0% stake. The filing indicates a slight decrease in ownership from the prior filing, where FMR reported 15,707,034.79 shares (amounts not directly comparable due to rounding), reflecting a modest reduction in Fidelity's position.

• · FMR LLC's beneficial ownership includes shares held by subsidiaries FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Strategic Advisers LLC.
• · Abigail P. Johnson, as part of the Johnson family group, may be deemed to form a controlling group with respect to FMR LLC under the Investment Company Act of 1940.
• · The filing is an amendment (SC 13G/A) and includes a joint filing agreement under Rule 13d-1(k)(1).

07-10-2026

FMR LLC filed an amended Schedule 13G disclosing beneficial ownership of 4,558,616 common shares of X4 Pharmaceuticals, Inc (XFOR), representing 4.6% of outstanding shares as of September 30, 2026. The filing reflects a routine institutional ownership disclosure, with no change in control intent. The stake is below the 5% threshold, indicating a passive investment position.

• · FMR LLC's ownership is below the 5% threshold, so no individual other person's interest exceeds 5% of total outstanding common stock.
• · The filing is made under Rule 13d-1(b) and includes a joint filing agreement under Rule 13d-1(k)(1).
• · Abigail P. Johnson and the Johnson family control FMR LLC through Series B voting shares and a shareholders' voting agreement.

07-10-2026

FMR LLC (Fidelity) filed a Schedule 13G/A with the SEC, disclosing beneficial ownership of 7,622,406.36 shares of Steven Madden, Ltd. (SHOO) common stock as of September 30, 2026, representing a 10.4% stake. The filing indicates Fidelity's holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · FMR LLC's beneficial ownership includes shares held by subsidiaries FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC.
• · Abigail P. Johnson and the Johnson family are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of voting power.
• · The filing is an amendment (Schedule 13G/A) and includes a joint filing agreement under Rule 13d-1(k)(1).
• · No single person other than FMR LLC and Abigail P. Johnson beneficially owns more than 5% of the outstanding common stock.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC, reporting beneficial ownership of 4,928,707 shares of WisdomTree, Inc. common stock as of September 30, 2026, representing 3.2% of the outstanding shares. The filing indicates a slight decrease in Fidelity's stake compared to the prior period, where they held 4,922,670 shares (3.2% of a smaller base). The filing is made under Rule 13d-1(b) and reflects Fidelity's passive investment intent, with no purpose or effect of changing or influencing control of WisdomTree.

• · FMR LLC's filing is an amendment to Schedule 13G, indicating a change in beneficial ownership from the prior filing.
• · The filing is made under Rule 13d-1(b), confirming Fidelity's passive investment status.
• · Abigail P. Johnson, as Chairman and CEO of FMR LLC, is also reported as a beneficial owner with the same 3.2% stake.
• · The filing includes a joint filing agreement under Rule 13d-1(k)(1) between FMR LLC and Abigail P. Johnson.
• · No single person other than FMR LLC and Abigail P. Johnson is known to have an interest in more than 5% of WisdomTree's common stock.

07-10-2026

FMR LLC (Fidelity) disclosed a 9.7% beneficial ownership stake in Silgan Holdings Inc. as of September 30, 2026, holding 10,204,399.08 shares of common stock. The filing is an amendment to Schedule 13G and confirms the shares were acquired in the ordinary course of business, not for control purposes. Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported as a beneficial owner with the same number of shares.

• · FMR LLC's ownership is held through its subsidiaries including FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC.
• · Fidelity Management & Research Company LLC beneficially owns 5% or greater of the outstanding shares.
• · The Johnson family group holds 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.

07-10-2026

FMR LLC (parent company of Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 5,877,330.42 common shares of Scotts Miracle-Gro Co (SMG) as of September 30, 2026, representing 10.1% of the outstanding stock. The filing is a routine ownership update with no change in control intent and reflects FMR's passive investment in the company.

• · The filing is under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not for changing or influencing control of the issuer.
• · Abigail P. Johnson, Chairman and CEO of FMR LLC, is also reported individually as a beneficial owner of the same number of shares (5,877,330.42, 10.1%).
• · FMR LLC's subsidiaries holding SMG shares include FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Strategic Advisers LLC.
• · The Johnson family group holds 49% of the voting power of FMR LLC through Series B voting common shares and a shareholders' voting agreement.
• · No single person's interest in the common stock exceeds 5% other than the reporting entities.
• · Filing date is October 6, 2026, with ownership snapshot as of September 30, 2026.

07-10-2026

FMR LLC filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 2,920,475.49 shares of Pursuit Attractions & Hospitality, Inc. (PRSU) common stock, representing 10.7% of the outstanding shares as of September 30, 2026. The filing is a routine disclosure of passive investment, with FMR LLC certifying the shares were not acquired to influence control. The ownership stake is significant but represents a passive investment, with no indication of changes in control or management.

• · FMR LLC's filing is an amendment to Schedule 13G, indicating a change in ownership from a prior filing.
• · The filing is made under Rule 13d-1(b), confirming the investment is passive and not intended to influence control.
• · FMR LLC's beneficial ownership includes shares held by its subsidiaries and affiliates, including Fidelity Management & Research Company LLC, which beneficially owns 5% or more of the outstanding shares.
• · Abigail P. Johnson and the Johnson family hold 49% of the voting power of FMR LLC through Series B voting common shares.
• · The filing was made jointly by FMR LLC and Abigail P. Johnson under a Rule 13d-1(k)(1) agreement.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 9,913,111.69 shares of Allegro MicroSystems, Inc. common stock as of September 30, 2026. This represents a 5.3% stake in the company, confirming Fidelity as a major shareholder. The filing is a routine disclosure of passive investment holdings and does not indicate any change in control intent.

• · The filing is an amendment (SC 13G/A) to a previous Schedule 13G.
• · FMR LLC's beneficial ownership includes shares held by multiple subsidiaries and affiliates, including FIAM LLC, Fidelity Management & Research Company LLC, and others.
• · Abigail P. Johnson, through family trusts and a voting agreement, may be deemed to form a controlling group with respect to FMR LLC under the Investment Company Act of 1940.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

07-10-2026

FMR LLC (Fidelity) disclosed a 12.6% beneficial ownership stake in Skyworks Solutions, Inc. as of September 30, 2026, holding 19,006,368.57 shares of common stock. The filing is a routine Schedule 13G by a passive institutional investor, indicating no change in control intent.

• · FMR LLC's filing is under Rule 13d-1(b), confirming passive investor status.
• · The filing date is October 7, 2026, with ownership measured as of September 30, 2026.
• · No single other person holds more than 5% of the outstanding common stock.
• · Abigail P. Johnson and the Johnson family hold 49% of the voting power of FMR LLC through Series B voting common shares.

07-10-2026

FMR LLC filed an amended Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 4,401,653.86 shares of PVH Corp. common stock, representing 9.5% of the outstanding shares as of September 30, 2026. The filing reflects FMR's continued significant stake in PVH, with no change in control intent, and includes a joint filing agreement among FMR entities and the Johnson family voting group.

• · Filing date: October 7, 2026; beneficial ownership as of September 30, 2026
• · FMR LLC is a Delaware limited liability company, with principal offices at 245 Summer Street, Boston, MA
• · Abigail P. Johnson is Chairman and CEO of FMR LLC; Johnson family controls 49% of FMR LLC voting power through Series B shares
• · Joint filing agreement under Rule 13d-1(k)(1) executed October 6, 2026
• · FMR LLC certifies shares were acquired and held in ordinary course of business, not to influence control

07-10-2026

FMR LLC (Fidelity) disclosed a 5.8% beneficial ownership stake in QuidelOrtho Corp as of September 30, 2026, holding 3,950,167.67 shares of common stock. The filing is an amendment (SC 13G/A) and confirms the holdings are passive in nature, with no intent to influence control of the company. The filing also notes that FMR LLC and its affiliates, including Fidelity Management & Research Company LLC and Strategic Advisers LLC, are part of the reporting group, with Abigail P. Johnson as the ultimate controlling person.

• · The filing is an amendment (SC 13G/A) filed on October 7, 2026, with a 'date as of change' of October 7, 2026.
• · FMR LLC's beneficial ownership includes shares held by its subsidiaries and affiliates, with Fidelity Management & Research Company LLC and Strategic Advisers LLC each owning 5% or greater of the outstanding shares.
• · The filing includes a Rule 13d-1(k)(1) joint filing agreement among the reporting entities.
• · Abigail P. Johnson is identified as the controlling person through her role and family ownership of Series B voting common shares of FMR LLC.
• · The filing explicitly states the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of QuidelOrtho Corp.

07-10-2026

FMR LLC (Fidelity) disclosed a 13.0% beneficial ownership stake in Repligen Corp as of September 30, 2026, holding 7,361,317.84 shares of common stock. The filing is an amendment to Schedule 13G, indicating passive investment intent, and was jointly filed with Abigail P. Johnson. No prior-period comparison is available in this filing, so no period-over-period changes can be reported.

• · FMR LLC holds sole voting power over 7,345,276.55 shares and sole dispositive power over 7,361,317.84 shares.
• · Abigail P. Johnson is deemed to have beneficial ownership of the same 7,361,317.84 shares (13.0%) through her control of FMR LLC.
• · The filing confirms that no other person's interest in Repligen common stock exceeds 5%.
• · The filing is made pursuant to Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to change or influence control.
• · Fidelity Management & Research Company LLC is the only subsidiary that beneficially owns 5% or more of the class.

07-10-2026

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 8,411,905.03 shares of Celldex Therapeutics, Inc. common stock as of September 30, 2026, representing 10.7% of the outstanding shares. The filing indicates FMR LLC holds this stake in the ordinary course of business and not with the purpose of influencing control of Celldex. The filing also notes that no other single person's interest in the stock exceeds 5% of the total outstanding shares.

• · FMR LLC's filing is an amendment (SC 13G/A) to a prior Schedule 13G.
• · The filing date is October 7, 2026, with a date as of change of October 7, 2026, and the ownership data is as of September 30, 2026.
• · FMR LLC certifies the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Celldex.
• · Abigail P. Johnson is a Director, Chairman, and CEO of FMR LLC; members of the Johnson family are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of the voting power.
• · A Rule 13d-1(k)(1) joint filing agreement is in place among the reporting entities.

07-10-2026

Alpine Associates Management Inc. filed a Schedule 13G with the SEC on October 7, 2026, disclosing beneficial ownership of 2,008,500 common shares of Sangoma Technologies Corp, representing a 6.04% stake. The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · Alpine Associates Management Inc. is based in Palm Beach, Florida.
• · The filing was made under Rule 13d-1(b) of the Securities Exchange Act of 1934.
• · The filing certifies that the shares were not acquired to change or influence control of Sangoma Technologies Corp.

07-10-2026

Bellevue Group AG and its wholly-owned subsidiary Bellevue Asset Management AG filed a Schedule 13G disclosing beneficial ownership of 1,000,000 shares of Yarrow Bioscience Inc. (formerly VYNE Therapeutics Inc.) common stock, representing a 10.6% stake as of September 14, 2026. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control.
• · Bellevue Asset Management AG is a wholly-owned subsidiary of Bellevue Group AG.
• · The beneficial ownership percentage is based on 9,437,693 shares outstanding as of September 14, 2026, after giving effect to the closing of an equity offering by the issuer.
• · The filers are regulated by the Swiss Financial Market Supervisory Authority (FINMA).

07-10-2026

Allspring Global Investments Holdings, LLC disclosed in a Schedule 13G/A filing with the SEC that it beneficially owns 1,161,421 shares of Innospec Inc. common stock, representing 4.7% of shares outstanding as of September 30, 2026. The filing indicates the shares are held for clients in the ordinary course of business and not for the purpose of changing or influencing control of Innospec.

• · The filing is an amendment (Schedule 13G/A), filed on October 7, 2026, with an event date of September 30, 2026.
• · Innospec Inc. is incorporated in Delaware with its business address in Englewood, Colorado.
• · Allspring Global Investments Holdings, LLC is incorporated in Delaware and based in Charlotte, North Carolina.
• · The filer certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
• · The filing includes a subsidiary list: Allspring Global Investments, LLC and Allspring Funds Management, LLC, both registered investment advisers.

07-10-2026

Anthony Pompliano and his firm Professional Capital Management (Inflection Points Inc) disclosed a passive increase in their beneficial ownership of Silvia, Inc. (formerly ProCap Financial, Inc.) to 18.45% of outstanding common stock, up from 17.37% in the prior filing. The increase was solely due to the company's share repurchases reducing the total shares outstanding, not from any new purchases by the reporting persons. Pompliano continues as Chairman and CEO of Silvia, and the firm remains prohibited from participating in the issuer's buyback program under the Silvia Merger Agreement.

• · The reporting persons did not acquire any shares in connection with this amendment; the ownership increase was passive due to issuer share repurchases.
• · Professional Capital Management is prohibited from participating in the issuer's share repurchase program for two years following the Silvia Merger Agreement closing date.
• · Pompliano, as CEO, participates in decisions regarding the share repurchase program but the firm itself cannot participate.
• · 453,426 escrow shares and any potential earnout shares are excluded from the reported beneficial ownership.
• · No transactions in common stock were effected by the reporting persons in the past 60 days except as described.

07-10-2026

Craig Wigglesworth filed an exit Schedule 13G/A with the SEC on October 7, 2026, disclosing that he has ceased to be a beneficial owner of more than 5% of CDT Equity Inc.'s common stock. After the company's 1-for-25 reverse stock split effective September 28, 2026, he directly owns 50,322 shares, representing approximately 3.4% of the 1,477,789 shares outstanding as of September 30, 2026. This filing is an exit filing, indicating a reduction in his ownership stake.

• · The filing is an exit filing, indicating Mr. Wigglesworth has fallen below the 5% beneficial ownership threshold.
• · The ownership percentage is calculated based on 1,477,789 shares outstanding as of September 30, 2026, as provided by the issuer.
• · The reverse stock split was 1-for-25, effective September 28, 2026.
• · Mr. Wigglesworth is a citizen of New Zealand, with a business address in Auckland, New Zealand.
• · The company was formerly known as Conduit Pharmaceuticals Inc. (name change on September 22, 2023) and Murphy Canyon Acquisition Corp. (name change on November 30, 2021).

07-10-2026

Madrone Partners, L.P. and related reporting persons filed Amendment No. 3 to their Schedule 13D for StoneCo Ltd., disclosing aggregate beneficial ownership of 25,228,161 Class A common shares (10.8% of shares outstanding as of December 31, 2025). On October 5, 2026, Madrone sold 750,000 shares in an open market sale at an average price of $11.90 per share, reducing its direct holdings to 24,589,276 shares (10.6%). The filing reflects a net reduction in the group's stake from the prior filing, though the overall position remains substantial.

• · The filing is Amendment No. 3 to the original Schedule 13D filed November 7, 2018.
• · Madrone sold 750,000 shares on October 5, 2026, at prices ranging from $11.75 to $12.02 per share (average $11.90).
• · No other transactions were effected by the Reporting Persons in the past 60 days.
• · The percentage calculations are based on 232,663,503 Class A common shares outstanding as of December 31, 2025 (per StoneCo's 20-F filed April 23, 2026).
• · All Reporting Persons are U.S. citizens; entities are Delaware-organized.

07-10-2026

Bitfury Top HoldCo B.V. and related parties filed Amendment No. 24 to their Schedule 13D, disclosing a combined beneficial ownership of 54,671,694 shares (13.2%) of Cipher Digital Inc. (formerly Cipher Mining Inc.) as of October 7, 2026. The filing details the settlement of two forward contracts: V3 Holding Ltd transferred 1,805,000 shares at $17.83 on September 28, 2026, and Bitfury Top HoldCo transferred 1,840,000 shares at $15.87 on October 5, 2026. These settlements reduced the group's holdings, but they remain the largest shareholder block.

• · The filing is Amendment No. 24 to Schedule 13D, originally filed September 23, 2021.
• · Bitfury Top HoldCo is the record holder of 25,603,382 shares (6.2%).
• · V3 Holding Ltd directly holds 29,068,312 shares.
• · Valerijs Vavilovs is the sole owner of V3 Holding Ltd, which is the majority owner of Bitfury Group Ltd., which in turn owns Bitfury Top HoldCo.
• · The first tranche of the V3 Forward Contract was settled on September 28, 2026, at a settlement price of $17.83, transferring 1,805,000 shares.
• · The first tranche of the Bitfury Top HoldCo Forward Contract was settled on October 5, 2026, at a settlement price of $15.87, transferring 1,840,000 shares.
• · The company changed its name from Cipher Mining Inc. to Cipher Digital Inc. on August 30, 2021.

07-10-2026

King Street Capital Management, L.P. and related entities filed a Schedule 13G disclosing beneficial ownership of 301,730 shares of New Fortress Energy Inc. Series A Mandatorily Convertible Preferred Stock as of September 30, 2026, representing a 12.3% stake based on 2,454,936 preferred shares outstanding. The filing is a routine passive ownership disclosure under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business without intent to influence control.

• · The filing is a Schedule 13G (passive investor) not a 13D (activist), indicating no intent to change or influence control.
• · King Street Capital Management, L.P. is a registered investment advisor managing various fund entities.
• · The reporting persons include King Street Capital Management GP, L.L.C. (general partner) and Brian J. Higgins (managing member).
• · All reporting persons share voting and dispositive power over the 301,730 preferred shares.
• · The preferred stock has a par value of $0.01 per share.
• · The filing date is October 7, 2026, with a date of change of September 30, 2026.

07-10-2026

Stone House Capital Management, LLC and related parties filed an amended Schedule 13D with the SEC, disclosing beneficial ownership of 5,500,000 Class A common shares of Designer Brands Inc. (DBI), representing approximately 12.7% of outstanding shares. On October 6, 2026, SH Capital Partners sold all of its 15,000 options (referencing 1,500,000 shares) with a $10.00 strike price and January 15, 2027 expiration for $0.145 per option, eliminating its options exposure. The filing updates ownership percentages based on 43,390,683 shares outstanding as of September 3, 2026.

• · The Schedule 13D was initially filed on June 11, 2026, and previously amended on September 15, 2026.
• · The options sold had an exercise price of $10.00 per share and were set to expire on January 15, 2027.
• · The sale of options occurred on October 6, 2026, for $0.145 per option.
• · The reporting persons disclaim beneficial ownership of securities they do not directly own.

07-10-2026

Thompson Davis & Co., Inc. filed an amended Schedule 13D/A disclosing beneficial ownership of 1,897,280 shares of Smith Midland Corp (SMID) common stock, representing 35.4% of the outstanding shares. The filing indicates the shares are held on behalf of clients in the ordinary course of business, with Thompson Davis serving as an investment adviser.

• · Filing is an amendment to Schedule 13D (SC 13D/A), filed on October 7, 2026.
• · Thompson Davis & Co., Inc. is a registered investment adviser (RIA) based in New York.
• · The shares are held in the ordinary course of business on behalf of clients, and Thompson Davis disclaims beneficial ownership except for pecuniary interest.
• · The filing date as of change is October 2, 2026.
• · No prior period comparison data is available in this filing.

07-10-2026

Linden Capital L.P. and related entities disclosed beneficial ownership of 1,500,000 Class A ordinary shares of Southport Acquisition Corp. II, representing approximately 6.9% of shares outstanding, as of October 5, 2026. The filing is a routine Schedule 13G under Rule 13d-1(c), indicating passive investment intent with no purpose of changing or influencing control of the issuer.

• · The filing is a Schedule 13G (passive investment), not a 13D (activist intent).
• · Reporting persons include Linden Capital L.P. (Bermuda), Linden GP LLC (Delaware), Linden Advisors LP (Delaware), and Siu Min Wong (citizen of China/Hong Kong and U.S.).
• · Linden GP is the general partner of Linden Capital; Linden Advisors is the investment manager; Mr. Wong is the principal owner and controlling person of both.
• · Principal business address for Linden Capital is Hamilton, Bermuda; for others, it is 590 Madison Avenue, New York, NY.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.